Last Price$94.11.8%
Market Cap$46.6B
P/EBITDA LTM
19.1x
5Y avg
23.3x
Medical - Instruments & Supplies industry
median
(0.1x)
Stock quality & Intrinsic value
6/10
(0.1%) overvalued
Alcon Inc. P/EBITDA LTM
Annual
Quarterly
Daily
Crunching data... Almost there!
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|
| P/EBITDA LTM | 33.7x | 39.1x | 23.3x | 18.0x | 19.5x |
Overvalued or undervalued?
Check the intrinsic value for ALC
and see if it's the right time to invest.
Alcon Inc. (ALC) P/EBITDA LTM comparison analysis
General
LTM P/EBITDA LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Alcon Inc.ALC
22.9x
8.5%
182.9%
10.3%
Median Peer Set
18.6x
1.7%
15.9%
10.3%
Repligen CorporationRGEN
102.9x
(21.1%)
(80.9%)
5.6%
Intuitive Surgical, Inc.ISRG
75.1x
17.2%
27.7%
27.8%
West Pharmaceutical Services, Inc.WST
22.9x
(1.9%)
(15.5%)
17.0%
ResMed Inc.RMD
20.9x
10.9%
13.4%
21.8%
Baxter International Inc.BAX
18.8x
(69.5%)
(100.0%)
(6.9%)
The Cooper Companies, Inc.COO
18.4x
8.4%
32.2%
10.1%
Becton, Dickinson and CompanyBDX
18.0x
4.2%
18.3%
8.4%
AptarGroup, Inc.ATR
12.9x
2.7%
30.2%
10.5%
Hologic, Inc.HOLX
12.0x
(0.0%)
81.1%
19.6%
Masimo CorporationMASI
(51.4x)
0.6%
(42.5%)
4.0%
ALC key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|
% growth | 6,518.0 0.0% | 6,596.0 1.2% | 6,792.0 3.0% | 7,153.0 5.3% | 7,508.0 5.0% | 6,833.0 (9.0%) | 8,291.0 21.3% | 8,717.0 5.1% | 9,455.0 8.5% |
| Cost of Goods Sold (COGS) | 3,394.6 | 3,485.0 | 3,588.0 | 3,961.0 | 3,846.0 | 3,893.0 | 3,639.0 | 3,969.0 | 4,208.0 |
% margin | 3,123.3 47.9% | 3,111.0 47.2% | 3,204.0 47.2% | 3,192.0 44.6% | 3,662.0 48.8% | 2,940.0 43.0% | 4,652.0 56.1% | 4,748.0 54.5% | 5,247.0 55.5% |
| Operating Expenses | 2,722.2 | 3,101.0 | 3,281.0 | 3,440.0 | 3,849.0 | 3,422.0 | 4,072.0 | 4,076.0 | 4,208.0 |
| Research & Development Expenses (R&D) | 440.6 | 499.0 | 584.0 | 587.0 | 656.0 | 673.0 | 842.0 | 702.0 | 859.0 |
| Selling, General & Administrative Expenses (SG&A) | 2,248.0 | 2,526.0 | 2,596.0 | 2,801.0 | 2,847.0 | 2,694.0 | 3,076.0 | 3,068.0 | 3,209.0 |
% margin | 401.1 6.2% | 10.0 0.2% | (77.0) (1.1%) | (248.0) (3.5%) | (187.0) (2.5%) | (482.0) (7.1%) | 580.0 7.0% | 672.0 7.7% | 1,039.0 11.0% |
| Interest Income | 17.0 | 1.0 | 0.0 | 2.0 | 8.0 | 6.0 | 3.0 | 16.0 | 34.0 |
| Interest Expense | 0.0 | 31.0 | 27.0 | 24.0 | 113.0 | 124.0 | 120.0 | 134.0 | 189.0 |
| Pre-tax Income | 337.6 | (113.0) | (127.0) | (300.0) | (332.0) | (635.0) | 418.0 | 463.0 | 832.0 |
% effective tax rate | 41.4 12.3% | 57.0 (50.4%) | (383.0) 301.6% | (73.0) 24.3% | 324.0 (97.6%) | (104.0) 16.4% | 42.0 10.0% | 128.0 27.6% | (142.0) (17.1%) |
% margin | 296.3 4.5% | (170.0) (2.6%) | 256.0 3.8% | (227.0) (3.2%) | (656.0) (8.7%) | (531.0) (7.8%) | 376.0 4.5% | 335.0 3.8% | 974.0 10.3% |
| EPS | 0.61 | (0.35) | 0.52 | (0.46) | (1.34) | (1.09) | 0.77 | 0.70 | 1.98 |
| Diluted EPS | 0.61 | (0.35) | 0.52 | (0.46) | (1.34) | (1.09) | 0.76 | 0.70 | 1.96 |
% margin | 1,567.0 24.0% | 1,170.0 17.7% | 1,217.1 17.9% | 1,352.1 18.9% | 1,256.1 16.7% | 1,112.0 16.3% | 1,760.7 21.2% | 1,776.4 20.4% | 2,242.0 23.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Alcon Inc.'s P/EBITDA LTM?
As of today, Microsoft Corp's last 12-month P/EBITDA LTM is 19.1x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/EBITDA LTM for Alcon Inc. have been 20.6x over the past three years, and 24.5x over the past five years.
2) Is Alcon Inc.'s P/EBITDA LTM Good?
As of today, Alcon Inc.'s P/EBITDA LTM is 19.1x, which is higher than industry median of (0.1x). It indicates that Alcon Inc.'s P/EBITDA LTM is Bad.